Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $5.14 USD
Change Today +0.08 / 1.58%
Volume 197.2K
OSUR On Other Exchanges
Symbol
Exchange
Frankfurt
As of 12:42 PM 07/30/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Anthony Zezzo II

Executive Vice President of Marketing and Sales, OraSure Technologies, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

61$998,955
As of Fiscal Year 2014

Background*

Mr. Anthony Zezzo, II, also known as Tony, has been an Executive Vice President of Marketing and Sales at OraSure Technologies, Inc. since January 4, 2011. Mr. Zezzo has overall responsibility for the OraSure Technologies Inc.'s global marketing and sales operations, which includes the domestic and international sales teams for its infectious disease and substance abuse businesses, marketing, and client services/customer care. He joined OraSure as an accomplished sales ...

Read Full Background

Corporate Headquarters*

220 East First Street
Bethlehem, Pennsylvania 18015

United States

Phone: 610-882-1820
Fax: 610-882-1830

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

Unknown/Other Education
Grove City College

Other Affiliations*

Annual Compensation*

Salary$375,812
Total Annual Compensation$375,812

Stock Options*

Restricted Stock Awards$166,524
Exercisable Options153,337
Exercisable Options Value$519,562
Unexercisable Options114,131
Unexercisable Options Value$433,540
Total Value of Options$953,101
Total Number of Options267,468

Total Compensation*

Total Annual Cash Compensation$582,652
Total Short Term Compensation$375,812
Other Long Term Compensation$166,524
Total Calculated Compensation$998,955
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OSUR:US $5.14 USD +0.08

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Paul Averback M.D., DABPFounder, Chairman, Chief Executive Officer, President and Member of Communications Committee
Nymox Pharmaceutical Corporation
$290.0K
John J. Sperzel III, B.Sc.Chief Executive Officer, President and Director
Chembio Diagnostics, Inc.
$298.6K
Hermes Chan Co-Founder, Chief Executive Officer, President, Director, Chief Executive Officer of Medmira Laboratories Inc and President of Medmira Laboratories Inc
MedMira Inc.
C$188.0K
Raymond F. Akers Jr., Ph.D.Co-Founder, Executive Chairman, Chief Executive Officer, President and Secretary
Akers Biosciences Inc.
$394.2K
Douglas L. Drysdale Chairman, Chief Executive Officer and President
Pernix Therapeutics Holdings, Inc.
$814.6K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ORASURE TECHNOLOGIES INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.